» Authors » Jessica J Bartoszko

Jessica J Bartoszko

Explore the profile of Jessica J Bartoszko including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 1533
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rudnick W, Cayen J, Bartoszko J, Belanger J, Bessey C, Bos S, et al.
Can J Hosp Pharm . 2024 Dec; 77(4):e3595. PMID: 39664368
Background: Antimicrobial use data from inpatients in northern Canada suitable to inform stewardship programs are limited. Objective: As a special project of the Canadian Nosocomial Infection Surveillance Program, to describe...
2.
Bartoszko J, Gutierrez Garcia M, Diaz Martinez J, Yegorov S, Brignardello-Petersen R, Mertz D, et al.
J Clin Epidemiol . 2023 Dec; 166:111238. PMID: 38081440
Objectives: Combining multivariate and network meta-analysis methods simultaneously in a multivariate network meta-analysis (MVNMA) provides the methodological framework to analyze the largest amount of evidence relevant to decision-makers (i.e., from...
3.
Zeraatkar D, Pitre T, Diaz-Martinez J, Chu D, Rochwerg B, Lamontagne F, et al.
Am J Epidemiol . 2023 May; 192(10):1678-1687. PMID: 37254775
We aimed to assess the impact of allocation concealment and blinding on the results of coronavirus disease 2019 (COVID-19) trials, using the World Health Organization COVID-19 database (to February 2022)....
4.
Rehman N, Wu M, Garcia C, Leenus A, El-Kechen H, Bhandari M, et al.
AIDS Patient Care STDS . 2023 Mar; 37(4):192-198. PMID: 36951646
People living with HIV (PLHIV) need lifelong medical care. However, retention in HIV care is not measured uniformly, making it challenging to compare or pool data. The objective of this...
5.
Bartoszko J, Elias Z, Rudziak P, Lo C, Thabane L, Mertz D, et al.
BMJ Open . 2022 Dec; 12(12):e063023. PMID: 36456018
Objectives: To quantify the prognostic effects of demographic and modifiable factors in streptococcal toxic shock syndrome (STSS). Design: Systematic review and meta-analysis. Data Sources: MEDLINE, EMBASE and CINAHL from inception...
6.
Bartoszko J, Mitchell R, Katz K, Mulvey M, Mataseje L
Microbiol Spectr . 2022 Aug; 10(4):e0097522. PMID: 35950772
Data regarding the epidemiology of extensively drug-resistant (XDR) carbapenemase-producing (CPE) in Canada are scarce. Among CPE patients identified by the Canadian Nosocomial Infection Surveillance Program, the following were each significantly...
7.
Jimenez-Mora M, Ramirez Varela A, Meneses-Echavez J, Bidonde J, Angarita-Fonseca A, Siemieniuk R, et al.
Syst Rev . 2021 Nov; 10(1):289. PMID: 34724980
Background: The coronavirus disease 19 (covid-19) pandemic has underscored the need to expedite clinical research, which may lead investigators to shift away from measuring patient-important outcomes (PIO), limiting research applicability....
8.
Ac Siemieniuk R, Bartoszko J, Diaz Martinez J, Kum E, Qasim A, Zeraatkar D, et al.
BMJ . 2021 Sep; 374:n2231. PMID: 34556486
Objective: To evaluate the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19). Design: Living systematic review and network meta-analysis,...
9.
Honarmand K, Penn J, Agarwal A, Siemieniuk R, Brignardello-Petersen R, Bartoszko J, et al.
J Clin Epidemiol . 2021 Jul; 139:68-79. PMID: 34274489
Objective: To describe the characteristics of Covid-19 randomized clinical trials (RCTs) and examine the association between trial characteristics and the likelihood of finding a significant effect. Study Design: We conducted...
10.
Bartoszko J, Siemieniuk R, Kum E, Qasim A, Zeraatkar D, Diaz Martinez J, et al.
BMJ . 2021 Apr; 373:n949. PMID: 33903131
Updates: This is the second version (first update) of the living systematic review, replacing the previous version (available as a data supplement). When citing this paper please consider adding the...